OraSure Technologies | OSUR - Selling And Administration Expenses


OraSure Technologies reported $13.21M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Agilent USD 476M 48M Dec/2025
AngioDynamics USD 36.57M 3.79M Sep/2025
Becton, Dickinson and Co. USD 1.21B 180M Mar/2026
Bio Techne USD 109.34M 4.35M Mar/2026
Bio-Rad Laboratories USD 221M 14.2M Dec/2025
Bruker USD 242.1M 5.1M Mar/2026
Cerus USD 19.33M 1.55M Dec/2024
Charles River Laboratories USD 159.42M 36.71M Mar/2026
Danaher USD 1.86B 166M Mar/2026
Dentsply International USD 351M 32M Mar/2026
Dexcom USD 349.7M 49.8M Mar/2026
Illumina USD 272M 11M Mar/2026
Integra LifeSciences USD 178.24M 21.79M Mar/2026
Intuitive Surgical USD 613.3M 73.8M Mar/2026
IQVIA Holdings USD 502M 34M Mar/2026
Mesa Laboratories USD 27.31M 380K Sep/2024
Mettler Toledo International USD 258.33M 1.5M Mar/2026
Myriad Genetics USD 122.3M 6.7M Dec/2025
OraSure Technologies USD 13.21M 3.29M Dec/2025
Quidel USD 199.3M 4.9M Mar/2026
Repligen USD 76.54M 2.17M Mar/2026
Revvity USD 253.88M 2.15M Mar/2026
STAAR Surgical USD 38.64M 299K Mar/2026
Thermo Fisher Scientific USD 1.8B 179M Mar/2026
Trinity Biotech USD 6.19M 2.18M Sep/2025
Waters USD 394M 153.99M Mar/2026